ต้นทุนประสิทธิผลของการใช้ Trastuzumab ร่วมลำดับแรกในมะเร็งเต้านมระยะ

trastuzumab  Intravenous trastuzumab is effective as a single-agent, and in combination with chemotherapy it significantly improves the median time to disease Self-Care Tips: · Drink at least two to three quarts of fluid every 24 hours, unless you are instructed otherwise · Trastuzumab causes little nausea · You may

If you're having trastuzumab to treat primary breast cancer after surgery, it's usually given for 1 year Some people may be offered Intravenous trastuzumab is effective as a single-agent, and in combination with chemotherapy it significantly improves the median time to disease

Trastuzumab deruxtecan Trastuzumab deruxtecan, sold under the brand name Enhertu, is an antibody-drug conjugate consisting of the humanized monoclonal Trastuzumab has also been shown to penetrate an impaired blood–brain barrier to a limited degree, such as during radiotherapy, and intrathecal delivery of